Previous studies have demonstrated that periconceptional folic acid/mu
ltivitamin supplementation reduced the occurrence of neural tube defec
ts. A case control analysis has been conducted in the dataset of the H
ungarian Case Control Surveillance of Congenital Abnormalities, 1980-1
991. In the study period, 54.9% of 30 663 pregnant women who had healt
hy babies (negative control group) were supplemented with high doses (
in general 2x3 mg) of folic acid per day. In those 17,300 pregnant wom
en who had offspring with congenital abnormalities, the rate of folic
acid supplementation was 50.4%. Exposure histories: preconceptional, I
, II, III, and IV-IX post-conceptional months were determined by recor
d reviews and questionnaire assessment. The case control pair analysis
showed a significant protection after folic acid supplementation duri
ng the critical period of cardiovascular defects, neural tube defects,
cleft lip with oi without cleft palate and posterior cleft palate. (C
) 1996 Wiley-Liss, Inc.